{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:12:43Z","timestamp":1759011163380},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.rdc.2011.01.003","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T18:50:32Z","timestamp":1301338232000},"page":"173-183","source":"Crossref","is-referenced-by-count":13,"title":["Inclusion Body Myositis: Diagnosis, Pathogenesis, and Treatment Options"],"prefix":"10.1016","volume":"37","author":[{"given":"Guillermo E.","family":"Solorzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Lawrence H.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rdc.2011.01.003_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis\u2014diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nmd.2007.11.001","article-title":"Sporadic inclusion body myositis: a continuing puzzle","volume":"18","author":"Needham","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.rdc.2011.01.003_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00002281-199811000-00005","article-title":"Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis","volume":"10","author":"Askanas","year":"1998","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2011.01.003_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","article-title":"Epidemiology of inclusion body myositis in the Netherlands: a nationwide study","volume":"55","author":"Badrising","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.rdc.2011.01.003_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I","article-title":"Prevalence of sporadic inclusion body myositis in Western Australia","volume":"23","author":"Phillips","year":"2000","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib6","first-page":"445","article-title":"Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota","volume":"35","author":"Wilson","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2011.01.003_bib7","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/art.10358","article-title":"Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis","volume":"46","author":"Shamim","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2011.01.003_bib8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.20766","article-title":"Genetics of inclusion-body myositis","volume":"35","author":"Needham","year":"2007","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nmd.2006.02.002","article-title":"Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1","volume":"16","author":"Scott","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.rdc.2011.01.003_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/mus.1178","article-title":"Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study","volume":"24","author":"Phillips","year":"2001","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ana.410400407","article-title":"Inclusion body myositis: clinical and pathological boundaries","volume":"40","author":"Amato","year":"1996","journal-title":"Ann Neurol"},{"issue":"2 Suppl 1","key":"10.1016\/j.rdc.2011.01.003_bib14","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/01.wnl.0000192260.33106.bb","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.rdc.2011.01.003_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2009.173823","article-title":"Inclusion body myositis: old and new concepts","volume":"80","author":"Amato","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.rdc.2011.01.003_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002281-200211000-00004","article-title":"Inclusion body myositis","volume":"14","author":"Tawil","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4065\/82.4.441","article-title":"Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients","volume":"82","author":"Oh","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.rdc.2011.01.003_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00005537-199807000-00009","article-title":"Dysphagia in patients with inclusion body myositis","volume":"108","author":"Houser","year":"1998","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.rdc.2011.01.003_bib19","first-page":"2009","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.45.5.993","article-title":"Inclusion body myositis presenting with isolated erector spinae paresis","volume":"45","author":"Hund","year":"1995","journal-title":"Neurology"},{"issue":"S1\/2","key":"10.1016\/j.rdc.2011.01.003_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-510X(00)00395-6","article-title":"Peripheral neuropathy associated with hereditary and sporadic inclusion body myositis: confirmation by electron microscopy and morphometry","volume":"179","author":"Hermanns","year":"2000","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","article-title":"Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis","volume":"21","author":"Koffman","year":"1998","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.57.3.548","article-title":"A\u00a0prospective natural history study of inclusion body myositis: implications for clinical trials","volume":"57","author":"Rose","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.rdc.2011.01.003_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.55.2.296","article-title":"Disease progression in sporadic inclusion body myositis: observations in 78 patients","volume":"55","author":"Peng","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ana.410410116","article-title":"Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations","volume":"41","author":"Dalakas","year":"1997","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"10.1016\/j.rdc.2011.01.003_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/112.3.727","article-title":"Inclusion body myositis. Observations in 40 patients","volume":"112","author":"Lotz","year":"1989","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.rdc.2011.01.003_bib27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mus.880131010","article-title":"Electrophysiological spectrum of inclusion body myositis","volume":"13","author":"Joy","year":"1990","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.rdc.2011.01.003_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nmd.2009.11.003","article-title":"Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008","volume":"20","author":"Hilton-Jones","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<138::AID-MUS22>3.0.CO;2-7","article-title":"The \u201csplit hand syndrome\u201d","volume":"23","author":"Wilbourn","year":"2000","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-8966(98)00027-3","article-title":"Distal myopathy with rimmed vacuoles","volume":"8","author":"Nonaka","year":"1998","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.rdc.2011.01.003_bib31","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mus.1167","article-title":"Clinical and genetic aspects of distal myopathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.rdc.2011.01.003_bib32","first-page":"1108","article-title":"Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy","volume":"257","author":"Reilich","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/mus.21377","article-title":"Dermatomyositis with inclusion body myositis pathology","volume":"40","author":"Layzer","year":"2009","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","article-title":"Muscle biopsy findings in inflammatory myopathies","volume":"28","author":"Dalakas","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.rdc.2011.01.003_bib36","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mus.20584","article-title":"Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis","volume":"34","author":"Greenberg","year":"2006","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nmd.2007.08.005","article-title":"Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis","volume":"18","author":"Nakano","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mus.20823","article-title":"Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis","volume":"36","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(91)90230-Q","article-title":"Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy","volume":"130","author":"Askanas","year":"1991","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.410390318","article-title":"Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis","volume":"39","author":"Askanas","year":"1996","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.rdc.2011.01.003_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.rdc.2011.01.003_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"issue":"17","key":"10.1016\/j.rdc.2011.01.003_bib45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000265398.77681.09","article-title":"T\u00a0cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis","volume":"69","author":"Salajegheh","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","article-title":"Sporadic inclusion body myositis: counts of different types of abnormal fibers","volume":"39","author":"Pruitt","year":"1996","journal-title":"Ann Neurol"},{"issue":"Pt 5","key":"10.1016\/j.rdc.2011.01.003_bib47","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awh148","article-title":"Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity","volume":"127","author":"Schmidt","year":"2004","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A\u00a0local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2011.01.003_bib49","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.45.7.1302","article-title":"Inclusion body myositis: explanation for poor response to immunosuppressive therapy","volume":"45","author":"Barohn","year":"1995","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.10121","article-title":"Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo","volume":"51","author":"Badrising","year":"2002","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib51","first-page":"22","article-title":"High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study","volume":"247","author":"Walter","year":"2000","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.rdc.2011.01.003_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00002281-200311000-00009","article-title":"Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging","volume":"15","author":"Askanas","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"2 Suppl 1","key":"10.1016\/j.rdc.2011.01.003_bib53","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","article-title":"Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition","volume":"66","author":"Askanas","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol"},{"issue":"12","key":"10.1016\/j.rdc.2011.01.003_bib55","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/jnnp.2009.174276","article-title":"Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid","volume":"80","author":"Muth","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.21115","article-title":"Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis","volume":"61","author":"Lunemann","year":"2007","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib57","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.21471","article-title":"Nature of \u201cTau\u201d immunoreactivity in normal myonuclei and inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"issue":"Pt 5","key":"10.1016\/j.rdc.2011.01.003_bib58","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.rdc.2011.01.003_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.21325","article-title":"Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta","volume":"64","author":"Kitazawa","year":"2008","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"10.1016\/j.rdc.2011.01.003_bib60","first-page":"e106","article-title":"Comment on \u2018Interrelation of inflammation and APP in sIBM: IL-1beta induces accumulation of beta-amyloid in skeletal muscle\u2019","volume":"132","author":"Greenberg","year":"2009","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib61","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00005072-199507000-00012","article-title":"Mitochondrial DNA deletions in muscle fibers in inclusion body myositis","volume":"54","author":"Oldfors","year":"1995","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.rdc.2011.01.003_bib62","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.21103","article-title":"Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells","volume":"61","author":"Dalakas","year":"2007","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib63","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.rdc.2011.01.003_bib64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","article-title":"A\u00a0controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM","volume":"56","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.rdc.2011.01.003_bib65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/01.WNL.0000071852.27182.C7","article-title":"Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study","volume":"61","author":"Lindberg","year":"2003","journal-title":"Neurology"},{"issue":"Pt 6","key":"10.1016\/j.rdc.2011.01.003_bib66","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.rdc.2011.01.003_bib67","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1093\/brain\/awp275","article-title":"Comment on alemtuzumab and inclusion body myositis","volume":"133","author":"Greenberg","year":"2010","journal-title":"Brain"},{"issue":"2 Suppl 1","key":"10.1016\/j.rdc.2011.01.003_bib68","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1212\/01.wnl.0000192258.32408.54","article-title":"Pilot trial of etanercept in the treatment of inclusion-body myositis","volume":"66","author":"Barohn","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.003_bib69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.WNL.0000134675.98525.79","article-title":"Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis","volume":"63","author":"Muscle Study Group","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.rdc.2011.01.003_bib70","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium induces autophagy by inhibiting inositol monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J\u00a0Cell Biol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X11000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X11000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T13:44:30Z","timestamp":1560087870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X11000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0889857X11000044"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2011.01.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}